pone.0261082.s001.pdf (240.01 kB)
In depth presentation of pertinent positive and negative glycan results.
journal contribution
posted on 2021-12-15, 18:41 authored by Jeffrey W. Brown, Koushik K. Das, Vasilios Kalas, Kiron M. Das, Jason C. MillsDas-1 IgG (at 5 & 50 μg/mL) and Das-1 IgM (at 5 μg/mL) are plotted logarithmically in A, B, and C respectively as the average relative fluorescence units (of 6 technical replicates) plus/minus standard deviation. The top 20 glycans for each arrays are listed below each array along with pertinent negative results. The complete data sets are provided in S1 Dataset (5 μg/mL IgG), S2 Dataset (50 μg/mL IgG), and S3 Dataset (5 μg/mL IgM) and are available for download on the Consortium for Functional Glycomics website (www.functionalglycomics.org).
(PDF)
History
Usage metrics
Categories
Keywords
western blot analysistumorigenic risk stratificationnear complete losslung carcinomas ).formerly called 7ecomprehensive glycan arraybarrett &# 82173 ’- sulfopancreatic ductal adenocarcinomamultiple previous studiestissue using immunohistochemistryclinically important antigenmonoclonal antibody dasc mab dasgastric adenocarcinomaxlink ">useful biomarkerused extensivelytype metaplasiatranslational applicationsstandard sourcerecently provenoncogenic transformationmultiple organsgastrointestinal systemcyst fluidcurrent paradigmschemically deglycosylatedcarcinomatous lesionsbasic scienceaberrantly expressed
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC